Identifying trajectories of the evolution of post-COVID-19 condition univ_paris_cite postcovid longcovid evolution COVID longCOVID SARSCoV2 infection symptoms
By Tarun Sai LomteMay 17 2023Reviewed by Lily Ramsey, LLM A recent study published in the International Journal of Infectious Diseases analyzed the evolution of the post-coronavirus disease 2019 condition for up to two years post-onset.
Most longitudinal studies described the prevalence of patients with symptoms at specific time points post-infection without identifying or defining distinct patient subgroups. The team included all adults in the cohort who had suspected or confirmed COVID-19 and at least one of the 53 symptoms within three months of onset that linger for at least two months.
Findings The study included 2,197 long COVID patients, predominately females , with a median age of 46. Most participants were enrolled before June 7, 2021, when SARS-CoV-2 Alpha was the predominant variant in France. Daily relapses were reported by half of these patients, which was consistent at 18 months post-onset. Less than weekly relapses were reported by 4% and 10% of these subjects at symptom onset and 18 months post-onset, respectively.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Are masks effective in the protection against COVID-19?Are masks effective in the protection against COVID-19? AnnalsofIM masks covid COVID19 SARSCoV2 pandemic publichealth health public epidemic protection transmission
Consulte Mais informação »
Study indicates that the Omicron wave and the rollout of vaccines led to almost 100% seropositivity and boosted anti-spike IgG titers in children and adolescentsStudy indicates that the Omicron wave and the rollout of vaccines led to almost 100% seropositivity and boosted anti-spike IgG titers in children and adolescents medrxivpreprint UZH_en omicron vaccines seropositivity igG covid COVID19 SARSCoV2
Consulte Mais informação »
Dresden jewel theft: Five men convicted of audacious 2019 heistIn 2019 the gang broke into a museum in Dresden and stole treasures worth €113 million (£98m).
Consulte Mais informação »
Estimated Rates of Incident and Persistent Chronic Pain Among US Adults, 2019-2020This cohort study uses data from the 2019-2020 National Health Interview Survey Longitudinal Cohort to assess rates of incident and persistent chronic pain and high-impact chronic pain among US adults across demographic groups.
Consulte Mais informação »
Met Police officer charged with rape after 2019 incidentPC Callum Utley is suspended from duty and is due at High Wycombe Magistrates' Court next week.
Consulte Mais informação »
Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 - Gut PathogensBackground Severe coronavirus disease 2019 (COVID-19) is associated with systemic hyper-inflammation. An adaptive interaction between gut microbiota and host immune systems is important for intestinal homeostasis and systemic immune regulation. The association of gut microbial composition and functions with COVID-19 disease severity is sparse, especially in India. We analysed faecal microbial diversity and abundances in a cohort of Indian COVID-19 patients to identify key signatures in the gut microbial ecology in patients with severe COVID-19 disease as well as in response to different therapies. The composition of the gut microbiome was characterized using 16Sr RNA gene sequences of genomic DNA extracted from faecal samples of 52 COVID-19 patients. Metabolic pathways across the groups were predicted using PICRUSt2. All statistical analyses were done using Vegan in the R environment. Plasma cytokine abundance at recruitment was measured in a multiplex assay. Results The gut microbiome composition of mild and severe patients was found to be significantly different. Immunomodulatory commensals, viz. Lachnospiraceae family members and Bifidobacteria producing butyrate and short-chain fatty acids (SCFAs), were under represented in patients with severe COVID-19, with an increased abundance of opportunistic pathogens like Eggerthella. The higher abundance of Lachnoclostridium in severe disease was reduced in response to convalescent plasma therapy. Specific microbial genera showed distinctive trends in enriched metabolic pathways, strong correlations with blood plasma cytokine levels, and associative link to disease outcomes. Conclusion Our study indicates that, along with SARS-CoV-2, a dysbiotic gut microbial community may also play an important role in COVID-19 severity through modulation of host immune responses.
Consulte Mais informação »